nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyproheptadine—CHRM3—ureter—cervical cancer	0.272	0.34	CbGeAlD
Cyproheptadine—CHRM3—exocrine gland—cervical cancer	0.0536	0.067	CbGeAlD
Cyproheptadine—HTR2B—uterine cervix—cervical cancer	0.0257	0.0321	CbGeAlD
Cyproheptadine—HTR2B—decidua—cervical cancer	0.0245	0.0306	CbGeAlD
Cyproheptadine—HTR2B—endometrium—cervical cancer	0.0233	0.0291	CbGeAlD
Cyproheptadine—SLC6A2—decidua—cervical cancer	0.0218	0.0272	CbGeAlD
Cyproheptadine—CHRM3—renal system—cervical cancer	0.0216	0.0271	CbGeAlD
Cyproheptadine—HTR1A—renal system—cervical cancer	0.0216	0.0269	CbGeAlD
Cyproheptadine—HTR2B—uterus—cervical cancer	0.0214	0.0268	CbGeAlD
Cyproheptadine—HTR2C—female reproductive system—cervical cancer	0.0205	0.0256	CbGeAlD
Cyproheptadine—CHRM1—female reproductive system—cervical cancer	0.0194	0.0242	CbGeAlD
Cyproheptadine—HTR2B—female reproductive system—cervical cancer	0.0193	0.0241	CbGeAlD
Cyproheptadine—HTR2B—vagina—cervical cancer	0.0174	0.0218	CbGeAlD
Cyproheptadine—CHRM3—female reproductive system—cervical cancer	0.0173	0.0217	CbGeAlD
Cyproheptadine—SLC6A2—female reproductive system—cervical cancer	0.0171	0.0214	CbGeAlD
Cyproheptadine—HRH1—epithelium—cervical cancer	0.0166	0.0207	CbGeAlD
Cyproheptadine—HRH1—uterine cervix—cervical cancer	0.0164	0.0206	CbGeAlD
Cyproheptadine—CHRM3—female gonad—cervical cancer	0.0158	0.0197	CbGeAlD
Cyproheptadine—HRH1—decidua—cervical cancer	0.0157	0.0196	CbGeAlD
Cyproheptadine—HRH1—endometrium—cervical cancer	0.0149	0.0186	CbGeAlD
Cyproheptadine—HRH1—mammalian vulva—cervical cancer	0.0144	0.018	CbGeAlD
Cyproheptadine—HTR2A—epithelium—cervical cancer	0.0139	0.0173	CbGeAlD
Cyproheptadine—HTR2A—renal system—cervical cancer	0.0128	0.0161	CbGeAlD
Cyproheptadine—HRH1—female reproductive system—cervical cancer	0.0123	0.0154	CbGeAlD
Cyproheptadine—HTR2B—lymph node—cervical cancer	0.0113	0.0141	CbGeAlD
Cyproheptadine—HRH1—female gonad—cervical cancer	0.0112	0.014	CbGeAlD
Cyproheptadine—HRH1—vagina—cervical cancer	0.0111	0.0139	CbGeAlD
Cyproheptadine—HTR2A—female reproductive system—cervical cancer	0.0103	0.0129	CbGeAlD
Cyproheptadine—SLC6A2—lymph node—cervical cancer	0.01	0.0125	CbGeAlD
Cyproheptadine—HTR2A—vagina—cervical cancer	0.00931	0.0116	CbGeAlD
Cyproheptadine—HRH1—lymph node—cervical cancer	0.00721	0.00901	CbGeAlD
Cyproheptadine—CHRM2—SIDS Susceptibility Pathways—HES1—cervical cancer	0.000781	0.0039	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling by GPCR—TAAR6—cervical cancer	0.000746	0.00373	CbGpPWpGaD
Cyproheptadine—HTR1A—GPCR ligand binding—WNT5A—cervical cancer	0.000698	0.00349	CbGpPWpGaD
Cyproheptadine—HTR2C—GPCR ligand binding—WNT5A—cervical cancer	0.000694	0.00347	CbGpPWpGaD
Cyproheptadine—HTR1A—GPCR downstream signaling—TAAR6—cervical cancer	0.000666	0.00333	CbGpPWpGaD
Cyproheptadine—HTR2C—GPCR downstream signaling—TAAR6—cervical cancer	0.000663	0.00332	CbGpPWpGaD
Cyproheptadine—CHRM1—Regulation of Actin Cytoskeleton—FGFR3—cervical cancer	0.00066	0.0033	CbGpPWpGaD
Cyproheptadine—CHRM3—Regulation of Actin Cytoskeleton—FGFR3—cervical cancer	0.000658	0.00329	CbGpPWpGaD
Cyproheptadine—CHRM2—Regulation of Actin Cytoskeleton—FGFR3—cervical cancer	0.000651	0.00326	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling by GPCR—WNT2—cervical cancer	0.000638	0.00319	CbGpPWpGaD
Cyproheptadine—HTR6—GPCR downstream signaling—AKAP13—cervical cancer	0.000617	0.00309	CbGpPWpGaD
Cyproheptadine—DRD2—GPCR ligand binding—WNT5A—cervical cancer	0.000612	0.00306	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling by GPCR—TAAR6—cervical cancer	0.000605	0.00303	CbGpPWpGaD
Cyproheptadine—HTR2A—GPCR ligand binding—WNT5A—cervical cancer	0.000603	0.00301	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling by GPCR—TAAR6—cervical cancer	0.000602	0.00301	CbGpPWpGaD
Cyproheptadine—HRH1—GPCR ligand binding—WNT5A—cervical cancer	0.000601	0.00301	CbGpPWpGaD
Cyproheptadine—CHRM1—GPCR ligand binding—WNT5A—cervical cancer	0.000599	0.003	CbGpPWpGaD
Cyproheptadine—CHRM3—GPCR ligand binding—WNT5A—cervical cancer	0.000598	0.00299	CbGpPWpGaD
Cyproheptadine—CHRM2—GPCR ligand binding—WNT5A—cervical cancer	0.000592	0.00296	CbGpPWpGaD
Cyproheptadine—DRD2—GPCR downstream signaling—TAAR6—cervical cancer	0.000585	0.00293	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling by GPCR—WNT2—cervical cancer	0.000583	0.00291	CbGpPWpGaD
Cyproheptadine—HTR2A—GPCR downstream signaling—TAAR6—cervical cancer	0.000576	0.00288	CbGpPWpGaD
Cyproheptadine—HRH1—GPCR downstream signaling—TAAR6—cervical cancer	0.000574	0.00287	CbGpPWpGaD
Cyproheptadine—CHRM1—GPCR downstream signaling—TAAR6—cervical cancer	0.000573	0.00286	CbGpPWpGaD
Cyproheptadine—CHRM3—GPCR downstream signaling—TAAR6—cervical cancer	0.000571	0.00285	CbGpPWpGaD
Cyproheptadine—CHRM2—GPCR downstream signaling—TAAR6—cervical cancer	0.000565	0.00283	CbGpPWpGaD
Cyproheptadine—HTR2B—GPCR downstream signaling—AKAP13—cervical cancer	0.000563	0.00282	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling by GPCR—AKAP13—cervical cancer	0.00056	0.0028	CbGpPWpGaD
Cyproheptadine—UGT1A3—Metabolism—CA9—cervical cancer	0.00054	0.0027	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling by GPCR—TAAR6—cervical cancer	0.000531	0.00266	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling by GPCR—TAAR6—cervical cancer	0.000523	0.00261	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling by GPCR—TAAR6—cervical cancer	0.000522	0.00261	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling by GPCR—TAAR6—cervical cancer	0.00052	0.0026	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling by GPCR—TAAR6—cervical cancer	0.000518	0.00259	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling by GPCR—TAAR6—cervical cancer	0.000513	0.00257	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling by GPCR—AKAP13—cervical cancer	0.000511	0.00256	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling by GPCR—WNT5A—cervical cancer	0.000484	0.00242	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—TAAR6—cervical cancer	0.000483	0.00241	CbGpPWpGaD
Cyproheptadine—HTR1A—SIDS Susceptibility Pathways—CASP3—cervical cancer	0.000479	0.00239	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling by GPCR—WNT2—cervical cancer	0.000472	0.00236	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling by GPCR—WNT2—cervical cancer	0.00047	0.00235	CbGpPWpGaD
Cyproheptadine—HTR1A—SIDS Susceptibility Pathways—CTNNB1—cervical cancer	0.000462	0.00231	CbGpPWpGaD
Cyproheptadine—HTR1A—GPCR downstream signaling—AKAP13—cervical cancer	0.000457	0.00228	CbGpPWpGaD
Cyproheptadine—HTR2C—GPCR downstream signaling—AKAP13—cervical cancer	0.000454	0.00227	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling by GPCR—WNT5A—cervical cancer	0.000441	0.00221	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—TAAR6—cervical cancer	0.000441	0.0022	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling by GPCR—WNT2—cervical cancer	0.000415	0.00207	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling by GPCR—AKAP13—cervical cancer	0.000415	0.00207	CbGpPWpGaD
Cyproheptadine—HTR2A—SIDS Susceptibility Pathways—CASP3—cervical cancer	0.000414	0.00207	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling by GPCR—AKAP13—cervical cancer	0.000413	0.00206	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling by GPCR—WNT2—cervical cancer	0.000408	0.00204	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling by GPCR—WNT2—cervical cancer	0.000407	0.00204	CbGpPWpGaD
Cyproheptadine—CHRM2—SIDS Susceptibility Pathways—CASP3—cervical cancer	0.000406	0.00203	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling by GPCR—WNT2—cervical cancer	0.000406	0.00203	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling by GPCR—WNT2—cervical cancer	0.000405	0.00202	CbGpPWpGaD
Cyproheptadine—DRD2—GPCR downstream signaling—AKAP13—cervical cancer	0.000401	0.00201	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling by GPCR—WNT2—cervical cancer	0.000401	0.002	CbGpPWpGaD
Cyproheptadine—HTR2A—SIDS Susceptibility Pathways—CTNNB1—cervical cancer	0.000399	0.00199	CbGpPWpGaD
Cyproheptadine—HTR2A—GPCR downstream signaling—AKAP13—cervical cancer	0.000395	0.00197	CbGpPWpGaD
Cyproheptadine—HRH1—GPCR downstream signaling—AKAP13—cervical cancer	0.000394	0.00197	CbGpPWpGaD
Cyproheptadine—CHRM1—GPCR downstream signaling—AKAP13—cervical cancer	0.000392	0.00196	CbGpPWpGaD
Cyproheptadine—CHRM2—SIDS Susceptibility Pathways—CTNNB1—cervical cancer	0.000391	0.00196	CbGpPWpGaD
Cyproheptadine—CHRM3—GPCR downstream signaling—AKAP13—cervical cancer	0.000391	0.00196	CbGpPWpGaD
Cyproheptadine—CHRM2—GPCR downstream signaling—AKAP13—cervical cancer	0.000387	0.00194	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—WNT2—cervical cancer	0.000377	0.00189	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling by GPCR—AKAP13—cervical cancer	0.000364	0.00182	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling by GPCR—AKAP13—cervical cancer	0.000358	0.00179	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling by GPCR—WNT5A—cervical cancer	0.000358	0.00179	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling by GPCR—AKAP13—cervical cancer	0.000358	0.00179	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—TAAR6—cervical cancer	0.000357	0.00179	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling by GPCR—AKAP13—cervical cancer	0.000356	0.00178	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling by GPCR—WNT5A—cervical cancer	0.000356	0.00178	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—TAAR6—cervical cancer	0.000356	0.00178	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling by GPCR—AKAP13—cervical cancer	0.000355	0.00178	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling by GPCR—AKAP13—cervical cancer	0.000352	0.00176	CbGpPWpGaD
Cyproheptadine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—cervical cancer	0.000349	0.00174	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—WNT2—cervical cancer	0.000344	0.00172	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—AKAP13—cervical cancer	0.000331	0.00166	CbGpPWpGaD
Cyproheptadine—CHRM1—Regulation of Actin Cytoskeleton—EGFR—cervical cancer	0.000326	0.00163	CbGpPWpGaD
Cyproheptadine—CHRM3—Regulation of Actin Cytoskeleton—EGFR—cervical cancer	0.000325	0.00162	CbGpPWpGaD
Cyproheptadine—CHRM2—Regulation of Actin Cytoskeleton—EGFR—cervical cancer	0.000322	0.00161	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling by GPCR—WNT5A—cervical cancer	0.000314	0.00157	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—TAAR6—cervical cancer	0.000314	0.00157	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling by GPCR—WNT5A—cervical cancer	0.000309	0.00155	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—TAAR6—cervical cancer	0.000309	0.00154	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling by GPCR—WNT5A—cervical cancer	0.000309	0.00154	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—TAAR6—cervical cancer	0.000308	0.00154	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling by GPCR—WNT5A—cervical cancer	0.000308	0.00154	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—TAAR6—cervical cancer	0.000307	0.00154	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling by GPCR—WNT5A—cervical cancer	0.000307	0.00153	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—TAAR6—cervical cancer	0.000306	0.00153	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling by GPCR—WNT5A—cervical cancer	0.000304	0.00152	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—TAAR6—cervical cancer	0.000303	0.00152	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—AKAP13—cervical cancer	0.000302	0.00151	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—WNT5A—cervical cancer	0.000286	0.00143	CbGpPWpGaD
Cyproheptadine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—cervical cancer	0.000281	0.00141	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—WNT2—cervical cancer	0.000279	0.0014	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—WNT2—cervical cancer	0.000278	0.00139	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—CA9—cervical cancer	0.00027	0.00135	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—WNT5A—cervical cancer	0.000261	0.0013	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—WNT2—cervical cancer	0.000245	0.00123	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—AKAP13—cervical cancer	0.000245	0.00123	CbGpPWpGaD
Cyproheptadine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—cervical cancer	0.000244	0.00122	CbGpPWpGaD
Cyproheptadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—cervical cancer	0.000244	0.00122	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—AKAP13—cervical cancer	0.000244	0.00122	CbGpPWpGaD
Cyproheptadine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—cervical cancer	0.000243	0.00122	CbGpPWpGaD
Cyproheptadine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—cervical cancer	0.000242	0.00121	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—WNT2—cervical cancer	0.000241	0.00121	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—WNT2—cervical cancer	0.000241	0.0012	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—WNT2—cervical cancer	0.00024	0.0012	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—WNT2—cervical cancer	0.000239	0.0012	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—WNT2—cervical cancer	0.000237	0.00118	CbGpPWpGaD
Cyproheptadine—DRD2—Circadian rythm related genes—TP53—cervical cancer	0.00022	0.0011	CbGpPWpGaD
Cyproheptadine—UGT1A3—Metabolism—MTHFR—cervical cancer	0.000219	0.0011	CbGpPWpGaD
Cyproheptadine—CHRM1—Circadian rythm related genes—TP53—cervical cancer	0.000215	0.00108	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—AKAP13—cervical cancer	0.000215	0.00108	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—AKAP13—cervical cancer	0.000212	0.00106	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—WNT5A—cervical cancer	0.000211	0.00106	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—AKAP13—cervical cancer	0.000211	0.00106	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—AKAP13—cervical cancer	0.000211	0.00105	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—WNT5A—cervical cancer	0.00021	0.00105	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—AKAP13—cervical cancer	0.00021	0.00105	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—AKAP13—cervical cancer	0.000208	0.00104	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—NOTCH2—cervical cancer	0.000201	0.001	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—WNT5A—cervical cancer	0.000186	0.000929	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—NOTCH2—cervical cancer	0.000183	0.000915	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—WNT5A—cervical cancer	0.000183	0.000914	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—WNT5A—cervical cancer	0.000182	0.000912	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—WNT5A—cervical cancer	0.000182	0.000909	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—WNT5A—cervical cancer	0.000181	0.000906	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—WNT5A—cervical cancer	0.000179	0.000897	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—HES1—cervical cancer	0.000164	0.000822	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—HES1—cervical cancer	0.00015	0.00075	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—NOTCH2—cervical cancer	0.000148	0.000742	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—NOTCH2—cervical cancer	0.000148	0.000738	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—TERT—cervical cancer	0.000144	0.00072	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—FGFR3—cervical cancer	0.000132	0.000661	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—TERT—cervical cancer	0.000131	0.000658	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—NOTCH2—cervical cancer	0.00013	0.000652	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—NOTCH2—cervical cancer	0.000128	0.000641	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—NOTCH2—cervical cancer	0.000128	0.00064	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—NOTCH2—cervical cancer	0.000128	0.000638	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—NOTCH2—cervical cancer	0.000127	0.000636	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—NOTCH2—cervical cancer	0.000126	0.00063	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—NOTCH1—cervical cancer	0.000124	0.000621	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—HES1—cervical cancer	0.000122	0.000609	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—HES1—cervical cancer	0.000121	0.000605	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—FGFR3—cervical cancer	0.000121	0.000603	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—NOTCH1—cervical cancer	0.000113	0.000567	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling by GPCR—EGFR—cervical cancer	0.000111	0.000553	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—MTHFR—cervical cancer	0.00011	0.000548	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—HES1—cervical cancer	0.000107	0.000534	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—TERT—cervical cancer	0.000107	0.000533	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—TERT—cervical cancer	0.000106	0.000531	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—HES1—cervical cancer	0.000105	0.000526	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—HES1—cervical cancer	0.000105	0.000525	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—HES1—cervical cancer	0.000105	0.000523	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—HES1—cervical cancer	0.000104	0.000521	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—HES1—cervical cancer	0.000103	0.000516	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling by GPCR—EGFR—cervical cancer	0.000101	0.000505	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—FGFR3—cervical cancer	9.79e-05	0.000489	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—FGFR3—cervical cancer	9.74e-05	0.000487	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—TERT—cervical cancer	9.36e-05	0.000468	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—MTOR—cervical cancer	9.3e-05	0.000465	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—TERT—cervical cancer	9.21e-05	0.000461	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—TERT—cervical cancer	9.19e-05	0.00046	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—NOTCH1—cervical cancer	9.19e-05	0.000459	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—TERT—cervical cancer	9.16e-05	0.000458	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—NOTCH1—cervical cancer	9.14e-05	0.000457	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—TERT—cervical cancer	9.13e-05	0.000457	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—TERT—cervical cancer	9.05e-05	0.000452	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—FGFR3—cervical cancer	8.59e-05	0.00043	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—CASP3—cervical cancer	8.55e-05	0.000428	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—MTOR—cervical cancer	8.49e-05	0.000425	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—FGFR3—cervical cancer	8.45e-05	0.000423	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—FGFR3—cervical cancer	8.44e-05	0.000422	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—FGFR3—cervical cancer	8.41e-05	0.000421	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—FGFR3—cervical cancer	8.38e-05	0.000419	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—FGFR3—cervical cancer	8.3e-05	0.000415	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—CTNNB1—cervical cancer	8.25e-05	0.000412	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling by GPCR—EGFR—cervical cancer	8.19e-05	0.000409	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling by GPCR—EGFR—cervical cancer	8.14e-05	0.000407	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—NOTCH1—cervical cancer	8.07e-05	0.000403	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—NOTCH1—cervical cancer	7.94e-05	0.000397	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—NOTCH1—cervical cancer	7.92e-05	0.000396	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—NOTCH1—cervical cancer	7.89e-05	0.000395	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—NOTCH1—cervical cancer	7.87e-05	0.000394	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—CASP3—cervical cancer	7.81e-05	0.00039	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—NOTCH1—cervical cancer	7.79e-05	0.00039	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—CTNNB1—cervical cancer	7.53e-05	0.000376	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—STAT3—cervical cancer	7.19e-05	0.000359	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling by GPCR—EGFR—cervical cancer	7.19e-05	0.000359	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling by GPCR—EGFR—cervical cancer	7.07e-05	0.000354	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling by GPCR—EGFR—cervical cancer	7.06e-05	0.000353	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling by GPCR—EGFR—cervical cancer	7.03e-05	0.000352	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling by GPCR—EGFR—cervical cancer	7.01e-05	0.000351	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling by GPCR—EGFR—cervical cancer	6.94e-05	0.000347	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—MTOR—cervical cancer	6.88e-05	0.000344	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—MTOR—cervical cancer	6.85e-05	0.000343	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—STAT3—cervical cancer	6.56e-05	0.000328	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—EGFR—cervical cancer	6.53e-05	0.000327	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—CASP3—cervical cancer	6.33e-05	0.000317	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—CASP3—cervical cancer	6.3e-05	0.000315	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—CTNNB1—cervical cancer	6.1e-05	0.000305	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—CTNNB1—cervical cancer	6.07e-05	0.000304	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—MTOR—cervical cancer	6.04e-05	0.000302	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—EGFR—cervical cancer	5.96e-05	0.000298	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—MTOR—cervical cancer	5.95e-05	0.000297	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—MTOR—cervical cancer	5.93e-05	0.000297	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—MTOR—cervical cancer	5.92e-05	0.000296	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—MTOR—cervical cancer	5.9e-05	0.000295	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—MTOR—cervical cancer	5.84e-05	0.000292	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—CASP3—cervical cancer	5.56e-05	0.000278	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—TP53—cervical cancer	5.48e-05	0.000274	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—CASP3—cervical cancer	5.47e-05	0.000274	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—CASP3—cervical cancer	5.46e-05	0.000273	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—CASP3—cervical cancer	5.44e-05	0.000272	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—CASP3—cervical cancer	5.42e-05	0.000271	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—CASP3—cervical cancer	5.37e-05	0.000269	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—CTNNB1—cervical cancer	5.36e-05	0.000268	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—STAT3—cervical cancer	5.32e-05	0.000266	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—STAT3—cervical cancer	5.29e-05	0.000265	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—CTNNB1—cervical cancer	5.27e-05	0.000264	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—CTNNB1—cervical cancer	5.26e-05	0.000263	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—CTNNB1—cervical cancer	5.24e-05	0.000262	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—CTNNB1—cervical cancer	5.23e-05	0.000261	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—CTNNB1—cervical cancer	5.18e-05	0.000259	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—TP53—cervical cancer	5.01e-05	0.00025	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—EGFR—cervical cancer	4.84e-05	0.000242	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—EGFR—cervical cancer	4.81e-05	0.000241	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—STAT3—cervical cancer	4.67e-05	0.000234	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—STAT3—cervical cancer	4.6e-05	0.00023	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—STAT3—cervical cancer	4.59e-05	0.000229	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—STAT3—cervical cancer	4.57e-05	0.000229	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—STAT3—cervical cancer	4.56e-05	0.000228	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—STAT3—cervical cancer	4.51e-05	0.000226	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—EGFR—cervical cancer	4.25e-05	0.000212	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—EGFR—cervical cancer	4.18e-05	0.000209	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—EGFR—cervical cancer	4.17e-05	0.000208	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—EGFR—cervical cancer	4.16e-05	0.000208	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—EGFR—cervical cancer	4.14e-05	0.000207	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—EGFR—cervical cancer	4.1e-05	0.000205	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—TP53—cervical cancer	4.06e-05	0.000203	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—TP53—cervical cancer	4.04e-05	0.000202	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—TP53—cervical cancer	3.56e-05	0.000178	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—TP53—cervical cancer	3.51e-05	0.000175	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—TP53—cervical cancer	3.5e-05	0.000175	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—TP53—cervical cancer	3.49e-05	0.000174	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—TP53—cervical cancer	3.48e-05	0.000174	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—TP53—cervical cancer	3.44e-05	0.000172	CbGpPWpGaD
